Amiodarone-associated 'torsade de pointes': Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease

Zeitschrift fur Kardiologie

Volumn 92, Issue 10, 2003, Pages 889-892

  Schrickel, J ^a   Bielik, H ^a   Yang, A ^a   Schwab, J O ^a   Shlevkov, N ^a   Schimpf, R ^a   Luderitz B ^a   Lewalter, T ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Amiodarone; Antiarrhythmic drugs; Proarrhythmia; QT time; Torsade de pointes

Indexed keywords

ACETYLDIGOXIN; AMIODARONE; BISOPROLOL; ELECTROLYTE;

AGED; ARTICLE; BRADYCARDIA; CASE REPORT; CEREBROVASCULAR ACCIDENT; DRUG BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HEART PROARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; RISK ASSESSMENT; SINUS RHYTHM; TORSADE DES POINTES;

ACETYLDIGOXINS; ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BISOPROLOL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; TORSADES DE POINTES;

EID: 0242320529     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0985-5     Document Type: Article

References (30)

1. Amiodaron trials meta-analysis investigators (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 350:1417-1424
2. Boutitie F, Boisel JP, Connolly SJ, Camm AJ, Cairns JA, Julian DG, Gent M, Janse MJ, Dorian P, Frangin G (1999) Amiodarone interaction with β-blockers: analysis of the merged EMIAT and CAMIAT databases. Circulation 99:2268-2275
3. Burkart F, Pfisterer M, Kiowski W et al (1990) Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: basel antiarrhythmic study of infarct survival (BASIS). J Am Coll Cardiol 16:1711-1718
4. Cairns JA, Connolly SJ, Gent M et al (1991) Post-myocardial infarction mortality in patients with ventricular premature depolarizations: Canadian amiodarone myocardial infarction arrhythmia trial pilot study. Circulation 84:550-557
5. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M et al (1992) Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 20:1056-1062
6. Connolly SJ (1999) Evidence-based analysis of amiodarone efficiacy and safety. Circulation 100:2025-2034
7. Doval HC, Nul DR, Grancelli HO et al (1994) Randomized trial of low-dose amiodarone in severe congestive heart failure (GESICA). Lancet 344: 493-498
8. Hamer AWF, Arkles LB, Johns JA (1989) Beneficial effects of low dose amiodarone in patients with congestive heart failure: a placebo-controlled trial. J Am Coll Cardiol 14: 1768-1774
9. Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinmann MM (1989) Long term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 13:442-449
10. Hohnloser S, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. Ann Intern Med 121:529-535
11. Hohnloser SH (1997) Proarrhythmic with class III antiarrhythmic drugs: types, risks, and management. Am J Cardiol 80:82G-89G
12. Kowey PR, Marinchak RA, Rials SJ, Bharucha D (1997) Pharmacologic and parmacokinetic profile of class III antiarrhythmic drugs. Am J Cardiol 80:16G-23G
13. Kusano KF, Hata Y, Yumoto A, Emori T, Sato T, Ohe T (2001) Torsade de pointes with a normal QT interval associated with hypokalemia: a case report. Jpn Circ J 65:757-760
14. Lewalter Th, Lüderitz B (2000) Arzneimitteltherapie der Herzrhythmusstörungen. Internist 41:S22-S33
15. Mason JW (1987) Amiodarone. N Engl J Med 316:455-466
16. Middlekauff HR, Stevenson WG, Saxon LA, Stevenson LW (1995) Amiodarone and torsade de pointes in patients with advanced heart failure. Am J Cardiol 76:449-502
17. Moro C, Romero J, Corres Peiretti MA (1986) Amiodarone and hypokalemia. A dangerous combination. Int J Cardiol 13:365-368
18. Nicklas JM, McKenna WJ, Stewart RA et al (1991) Prospective, doubleblind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 122:1016-1021
19. Roden DM, Woosley RL, Primm RK (1986) Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 111:1088-1096
20. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg, MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B (2000) Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913-920
21. Sclarovsky S, Lewin RF, Kracoff O, Strasberg B, Arditti A, Agmon J (1983) Amiodarone-induced polymorphous ventricular tachycardia. Am Heart J 105:6-12
22. Silvetti MS, Drago F, Bevilacqua M, Ragonese P (2001) Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy. Ital Heart J 2:231-236
23. Skanes AC, Morton BC, Green MS, Tang AS (1997) Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade. Can J Cardiol 13:383-386
24. Soyka LF, Wirtz C, Spangenberg RB (1990) Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 65:74A-81A
25. Tran HT, Chow MSS, Kluger J (1997) Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia. PACE 20:2275-2278
26. Trohmann RG, Sahu J (1999) Drug-induced torsade de pointes. Circulation 99:1-3
27. Vaughan Williams ME (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olesen KH (eds) Cardiac arrhythmias. Astra Södertälje, pp 449-469
28. Weinberg BA, Miles WM, Klein LS, Bolander JE, Dusmann RE, Stanton MS, Heger JJ, Langefeld C, Zipes DP (1993) Five-year follow up of 589 patients treated with amiodarone. Am Heart J 125:109-120
29. Wilson JS, Podrid PJ (1991) Side effects from amiodarone. Am Heart J 121:158-171
30. Yamada S, Kuga K, Yamaguchi I (2001) Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy. Jpn Circ J 65: 236-238